- Home
- ZKIN vs APM Comparison
ZKIN vs APM Comparison
Compare ZKIN & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZKIN
- APM
- Stock Information
- Founded
- ZKIN 2015
- APM 2010
- Country
- ZKIN China
- APM United Kingdom
- Employees
- ZKIN N/A
- APM N/A
- Industry
- ZKIN Metal Fabrications
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- ZKIN Industrials
- APM Health Care
- Exchange
- ZKIN Nasdaq
- APM Nasdaq
- Market Cap
- ZKIN 6.5M
- APM 6.7M
- IPO Year
- ZKIN 2017
- APM 2018
- Fundamental
- Price
- ZKIN N/A
- APM N/A
- Analyst Decision
- ZKIN
- APM
- Analyst Count
- ZKIN 0
- APM 0
- Target Price
- ZKIN N/A
- APM N/A
- AVG Volume (30 Days)
- ZKIN 19.5K
- APM 27.0K
- Earning Date
- ZKIN 01-01-0001
- APM 04-29-2025
- Dividend Yield
- ZKIN N/A
- APM N/A
- EPS Growth
- ZKIN N/A
- APM N/A
- EPS
- ZKIN N/A
- APM 0.00
- Revenue
- ZKIN $108,199,877.00
- APM N/A
- Revenue This Year
- ZKIN N/A
- APM $157,729.10
- Revenue Next Year
- ZKIN N/A
- APM N/A
- P/E Ratio
- ZKIN N/A
- APM $211.71
- Revenue Growth
- ZKIN N/A
- APM N/A
- 52 Week Low
- ZKIN $0.29
- APM $0.46
- 52 Week High
- ZKIN $3.18
- APM $9.50
- Technical
- Relative Strength Index (RSI)
- ZKIN 31.16
- APM 32.40
- Support Level
- ZKIN $1.30
- APM $0.80
- Resistance Level
- ZKIN $1.35
- APM $0.88
- Average True Range (ATR)
- ZKIN 0.11
- APM 0.07
- MACD
- ZKIN -0.02
- APM -0.01
- Stochastic Oscillator
- ZKIN 0.00
- APM 0.16
About ZKIN ZK International Group Co. Ltd
ZK International Group Co Ltd is engaged in the manufacture and marketing of metal pipes. The company is specialized in producing double-press thin-walled stainless steel tubes and fittings, carbon steel tubes and fittings, single-press tubes and fittings, and stainless-steel strips. The products are used in restaurants, hotels, hospitals, firefighting, food, beverage, ships, engines, industrial seawater desalination and systems of direct-drinking water, cold /hot water supply, city water supply, and gas of large/middle scale construction projects.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.